GLA c.962A>G ;(p.Q321R)

Variant ID: X-100653395-T-C

NM_000169.2(GLA):c.962A>G;(p.Q321R)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Lentivirus-mediated gene therapy for Fabry disease.

Nature Communications
Khan, Aneal A; Barber, Dwayne L DL; Huang, Ju J; Rupar, C Anthony CA; Rip, Jack W JW; Auray-Blais, Christiane C; Boutin, Michel M; O'Hoski, Pamela P; Gargulak, Kristy K; McKillop, William M WM; Fraser, Graeme G; Wasim, Syed S; LeMoine, Kaye K; Jelinski, Shelly S; Chaudhry, Ahsan A; Prokopishyn, Nicole N; Morel, Chantal F CF; Couban, Stephen S; Duggan, Peter R PR; Fowler, Daniel H DH; Keating, Armand A; West, Michael L ML; Foley, Ronan R; Medin, Jeffrey A JA
Publication Date: 2021-02-25

Variant appearance in text: GLA: Gln321Arg
PubMed Link: 33633114
Variant Present in the following documents:
  • Main text
  • 41467_2021_Article_21371.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: GLA: Q321R
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Comparative study of structural changes caused by different substitutions at the same residue on α-galactosidase A.

Plos One
Saito, Seiji S; Ohno, Kazuki K; Sakuraba, Hitoshi H
Publication Date: 2013

Variant appearance in text: GLA: Q321R
PubMed Link: 24386359
Variant Present in the following documents:
  • Main text
  • pone.0084267.pdf
View BVdb publication page